HI HB183 | 2023 | Regular Session
Note: Carry Foward to future HB183
Status
Spectrum: Strong Partisan Bill (Democrat 16-1)
Status: Introduced on January 19 2023 - 25% progression, died in committee
Action: 2023-01-25 - Referred to HLT, EDN, JHA, referral sheet 1
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 19 2023 - 25% progression, died in committee
Action: 2023-01-25 - Referred to HLT, EDN, JHA, referral sheet 1
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires all private schools to develop and implement comprehensive action plans for the management of anaphylaxis in their respective schools, including administration of auto-injectable epinephrine. Establishes certain immunity from liability for designated private school employees and agents who administer auto-injectable epinephrine during emergencies.
Title
Relating To Education.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-01-25 | House | Referred to HLT, EDN, JHA, referral sheet 1 |
| 2023-01-19 | House | Introduced and Pass First Reading. |
| 2023-01-18 | House | Pending introduction. |
Same As/Similar To
HB183 (Carry Over) 2023-01-25 - Referred to HLT, EDN, JHA, referral sheet 1
SB1213 (Same As) 2023-01-27 - Referred to HHS/EDU, JDC.
SB1213 (Same As) 2023-01-27 - Referred to HHS/EDU, JDC.
Subjects
Anaphylaxis Management
Auto-injectable Epinephrine
Comprehensive Action Plans
Designated School Employee and Agents
Immunity from Liability
Private Schools
Auto-injectable Epinephrine
Comprehensive Action Plans
Designated School Employee and Agents
Immunity from Liability
Private Schools
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=183&year=2023 |
| Text | https://www.capitol.hawaii.gov/sessions/session2023/bills/HB183_.HTM |
